Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3

CONTEXT: Growth hormone deficiency (GHD) in children is currently treated with daily injections of GH, which can be burdensome for patients and their parents/guardians. Somapacitan is a GH derivative in development for once-weekly treatment of GHD. OBJECTIVE: This work aimed to assess the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sävendahl, Lars, Battelino, Tadej, Højby Rasmussen, Michael, Brod, Meryl, Röhrich, Sebastian, Saenger, Paul, Horikawa, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505532/
https://www.ncbi.nlm.nih.gov/pubmed/36995872
http://dx.doi.org/10.1210/clinem/dgad183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505532/
https://www.ncbi.nlm.nih.gov/pubmed/36995872
http://dx.doi.org/10.1210/clinem/dgad183

Ejemplares similares